Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-040521
Filing Date
2025-04-29
Accepted
2025-04-29 06:11:47
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-29

Document Format Files

Seq Description Document Type Size
1 ARS tm2513103d2_ars.pdf ARS 8202390
  Complete submission text file 0001104659-25-040521.txt   11295255
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38129 | Film No.: 25882495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)